Immediate Impact
51 standout
Citing Papers
Non-small-cell lung cancer
2024 Standout
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Works of W. Appel being referenced
Nivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged ≥70 years and with poor performance status
2017
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| W. Appel | 261 | 377 | 104 | 240 | 13 | 595 | |
| J L Yeoh | 272 | 430 | 25 | 356 | 10 | 625 | |
| Lee Re | 204 | 146 | 98 | 145 | 23 | 725 | |
| Satoshi Okada | 72 | 109 | 126 | 174 | 22 | 730 | |
| Yoriko De Sanctis | 90 | 170 | 228 | 176 | 24 | 714 | |
| S Sawada | 223 | 88 | 86 | 134 | 18 | 710 | |
| Kyung Cho | 148 | 137 | 17 | 192 | 18 | 559 | |
| Kuhn‐Uk Lee | 398 | 406 | 67 | 33 | 9 | 696 | |
| Mary Ann Hederman | 177 | 131 | 40 | 199 | 12 | 699 | |
| Jenny M. Whitworth | 54 | 190 | 85 | 73 | 22 | 532 | |
| R. Swindell | 67 | 243 | 45 | 80 | 20 | 598 |
All Works
Loading papers...